Cabaletta Bio (CABA) Other Working Capital Changes (2022 - 2025)
Cabaletta Bio's (CABA) quarterly Other Working Capital Changes came in at -$1.1 million in Q4 2025, down 237.99% year-on-year from $766000.0 in Q4 2024, and little changed quarter-over-quarter from -$1.1 million in Q3 2025.
Cabaletta Bio (CABA) Other Working Capital Changes (2022 - 2025) Analysis & Trends
Cabaletta Bio's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$1.1 million for Q4 2025.
- On a quarterly basis, Other Working Capital Changes fell 237.99% year-over-year to -$1.1 million in Q4 2025; TTM through Dec 2025 was -$4.2 million, a 28.44% decrease from a year earlier, with the FY2025 full-year figure at -$4.2 million, down 28.44% from the prior year.
- Other Working Capital Changes held at -$1.1 million in Q4 2025 per CABA's latest filing, from -$1.1 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.3 million in Q4 2021 and bottomed at -$1.5 million in Q2 2021.
- The 5-year median for Other Working Capital Changes is $104500.0 (2025), against an average of $172050.0.
- Across the five-year window, Other Working Capital Changes jumped 202.54% in 2024 and slumped 237.99% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at -$2.9 million in 2022, then surged by 74.33% to -$747000.0 in 2023, then soared by 202.54% to $766000.0 in 2024, then slumped by 237.99% to -$1.1 million in 2025.
- Per Business Quant, the three latest CABA Other Working Capital Changes figures stand at -$1.1 million (Q4 2025), -$1.1 million (Q3 2025), and -$1.1 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cabaletta Bio | 182.04 Mn | 182.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.06 Mn |
| Dec 31, 2025 | -1.06 Mn |
| Dec 31, 2025 | -1.06 Mn |
| Sep 30, 2025 | -1.06 Mn |
| Sep 30, 2025 | -1.06 Mn |
| Sep 30, 2025 | -1.06 Mn |
| Jun 30, 2025 | -1.06 Mn |
| Jun 30, 2025 | -1.06 Mn |
| Jun 30, 2025 | -1.06 Mn |
| Mar 31, 2025 | -1.06 Mn |
| Mar 31, 2025 | -1.06 Mn |
| Mar 31, 2025 | -1.06 Mn |
| Dec 31, 2024 | 766,000.00 |
| Dec 31, 2024 | 766,000.00 |
| Dec 31, 2024 | 766,000.00 |
| Sep 30, 2024 | -1.84 Mn |
| Sep 30, 2024 | -1.84 Mn |
| Sep 30, 2024 | -1.84 Mn |
| Jun 30, 2024 | -968,000.00 |
| Jun 30, 2024 | -968,000.00 |